Dane Andreeff, Director at HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT), bought 50,000 shares at $0.56 ($28K) on 2020-05-14, disclosed to the SEC on 2020-05-19.
Open-market purchase of $28k HSDT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.56 | 1,526 | $855 | 3.1% |
| 2 | $0.56 | 5,679 | $3K | 11.4% |
| 3 | $0.56 | 15,810 | $9K | 31.6% |
| 4 | $0.56 | 26,985 | $15K | 54.0% |
| Total | $0.56 avg | 50,000 | $28K | 100% |
| Filing → |
| HSDT | BUY | 2023-08-30 | $71K | — | Filing → |
| HSDT | BUY | 2022-12-19 | $20K | — | Filing → |
| HSDT | BUY | 2022-11-25 | $29K | — | Filing → |